Overview
Hemas is a diversified Sri Lankan group spanning healthcare, consumer brands, mobility, leisure, travel, aviation and logistics. The latest quarter showed a clear split: sales and operating profit advanced, but higher costs after operating profit left net earnings slightly lower. Its completed majority investment in Kenya's Twiga adds an East African consumer platform, although the disclosed terms do not quantify the acquired business's revenue or profit contribution.
Price performance
At LKR 33.10 on 13 November 2026, the share gained 8.8% over one month, behind the ASPI's 10.3%, and fell 7.5% over one year against a 4.7% ASPI decline. The relative record is therefore mixed rather than a broad market-like move.
The price sits 61.2% of the way from its 52-week low to high. Recent volatility was quieter than its own one-year norm, while 20-day volume was above the preceding 60-day pace. The three-year record shows two falls of 15% or more, the deepest 24%, which took seven months to recover. Median daily turnover was LKR 5.2 million, and a LKR 1 million order is about 19% of what trades on a typical day, a noticeable part of a day's trading.
Valuation
At 11.1 times P/E, the market pays LKR 11.10 for every LKR 1 of trailing profit, below the diversified-holdings median of 14.8 times. P/B is 1.72 times, or LKR 1.72 for each LKR 1 of net assets, above the sector median of 1.18 times; FY2026 ROE of 15.7% helps explain why the shares do not trade at the sector's book multiple.
The 3.0% dividend yield is supported by FY2026 dividends of LKR 1.00 per share, up from LKR 0.90 in FY2025. P/E is cheaper than 62% of days since January 2019, but P/B is more expensive than 77% of days over that record. A buyer at this price relies on the latest quarter for 23.4% of trailing EPS; if that quarter had retained its year-ago net margin, P/E would be 10.6 times rather than 11.1 times.
News and sentiment
Direct coverage was normal, with 25 material articles over 90 days split between 12 positive, 10 negative and three neutral. The 6 November results coverage consistently reported strong September-quarter sales growth but lower earnings as finance costs rose.
Hemas reported on 6 November that it had completed the acquisition of a 75% stake in Kenya's Twiga Stationers and Printers for US$16.2 million. This extends the Consumer Brands footprint into East Africa, but Twiga's revenue and earnings were not disclosed, so its contribution cannot yet be sized against Hemas's operations. A LKR 0.25 first interim dividend has a confirmed 16 November 2026 ex-date.
Financials
September-quarter revenue rose 17.1% to LKR 37.8 billion, while operating profit increased 8.1% to LKR 3.8 billion. Gross margin was 29.7% against 32.8% a year earlier, operating margin was 10.0% against 10.8%, and net margin was 5.6% against 6.7%. Each measure was middling against the group's prior September quarters, so the margin compression is not an extreme result in its own comparable record.
Net profit slipped 1.7% to LKR 2.1 billion even though operating profit grew. Charges below operating profit took LKR 1.7 billion, meaning finance costs, tax and other non-operating items absorbed a larger share of the operating result. This is why the profit behind the share price grew more slowly than sales.
The latest balance sheet reported LKR 59.6 billion of total equity and 3.0 billion shares, the same share count used for current book value. The May 2025 one-for-five share subdivision mechanically changed historic per-share figures, so earnings performance is better judged from absolute profit and revenue.
Risks
The main risk is the sharp rise in funding needs after the March year-end. Total debt was LKR 18.4 billion at September, versus LKR 6.1 billion at March, while finance cost rose to LKR 464 million from LKR 186 million a year earlier. News coverage attributed the increase to working-capital borrowings and the Twiga acquisition, and this explains why operating growth did not translate into higher net profit.
The latest annual balance sheet was nevertheless conservatively financed: gearing, meaning debt against owners' equity, was 10.8%, down from 15.2%, and operating profit covered interest 13.8 times, up from 9.1 times. The current ratio was 1.72 times versus 1.64 times, meaning short-term assets including inventories and receivables exceeded bills due within a year. Cash conversion was 0.83 times, below 0.98 times, so not all annual operating profit arrived as cash.
Healthcare accounts for 62% of reported segment revenue and consumer retail 38%. The sector backdrop includes higher inflation and fuel costs, which are relevant cost and demand risks for those businesses, but the data does not establish a direct effect on Hemas.
Outlook
As at 14 November 2026, the next decisive update is the December 2026 interim filing, expected between 6 and 14 February 2027. It will show whether the September sales rebound and the higher borrowing burden persisted after the Twiga acquisition, and will supersede the financial figures used here.
The confirmed LKR 0.25 interim dividend goes ex-dividend on 16 November 2026 and is payable on 4 December 2026. The available data cannot yet separate Twiga's earnings contribution from the wider Consumer Brands result.